Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.

[1]  H. Whittle,et al.  Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial , 2008, BMJ : British Medical Journal.

[2]  H. Whittle,et al.  Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial , 2008, BMJ : British Medical Journal.

[3]  B. Bibby,et al.  Effect of vitamin A supplementation with BCG vaccine at birth on vitamin A status at 6 wk and 4 mo of age. , 2007, The American journal of clinical nutrition.

[4]  Maria Yazdanbakhsh,et al.  Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. , 2007, The American journal of clinical nutrition.

[5]  Peter Aaby,et al.  Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies , 2003, The Lancet.

[6]  P. Aaby,et al.  Routine vaccinations and child survival in a war situation with high mortality: effect of gender. , 2002, Vaccine.

[7]  C. Martins.  Níveis de anticorpos contra o sarampo entre as mulheres em idade fértil na população da Guiné-Bissau expostas a sarampo natural e a imunização contra o sarampo , 2002 .

[8]  W. Banya,et al.  Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population. , 2001, Journal of health, population, and nutrition.

[9]  Peter M. Johnson,et al.  Placental antibody transfer: influence of maternal HIV infection and placental malaria , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[10]  H. Whittle,et al.  Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa , 1997, The Lancet.

[11]  H. Whittle,et al.  Long–term survival in trial of medium–titre Edmonston–Zagreb measles vaccine in Guinea–Bissau: five–year follow–up , 1994, Epidemiology and Infection.

[12]  C. Hart,et al.  Reduced transfer of tetanus antibodies with placental malaria , 1994, The Lancet.

[13]  H. Whittle,et al.  Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age. , 1994, Vaccine.

[14]  L. Rossi Bernardi,et al.  Evaluation of prevalence of "doping" among Italian athletes , 1990, The Lancet.

[15]  H. Whittle,et al.  Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine , 1990, The Lancet.

[16]  P. Aaby,et al.  Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. , 1984, The Journal of infection.

[17]  E. Norrby.  Hemagglutination by measles virus. III. Identification of two different hemagglutinins. , 1963, Virology.

[18]  E. Norrby.  Hemagglutination by Measles Virus. 4. A Simple Procedure for Production of High Potency Antigen for Hemagglutination-Inhibition (HI) Tests , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.